Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1

Authors


Dr D. Dimitroulopoulos, 35 Parnassou str., GR-152 34 Halandri, Athens, Greece. E-mail: dimdim@otenet.gr

Abstract

Summary.  Immune thrombocytopenic purpura is an acquired disorder characterized by severe thrombocytopenia and caused by one or more antiplatelet autoantibodies. We present a case of a 20-year-old woman referred to our Unit for chronic hepatitis  C virus (HCV) infection. At week 28 of treatment with interferon (alfacon-1), undetectable HCV RNA and transaminase levels within normal limits, the patient presented with immune thrombocytopenic purpura, which was successfully treated with immunoglobulin and methylprednisolone. Despite the high doses and long life of corticosteroid treatment HCV RNA remained undetectable.

Ancillary